Black, Hispanic patients significantly less likely to receive key addiction medications, study finds
Black and Hispanic people are “significantly less likely” to receive two medications used to treat opioid addiction, according to a new study.
Black and Hispanic people are “significantly less likely” to receive two medications used to treat opioid addiction, according to a new study.
Compared to white patients, Black and Hispanic patients were 17.1% and 16.2% less likely, respectively, to receive either buprenorphine or naltrexone within 180 days of a health care event related to their substance use, like a nonfatal overdose or addiction-related infection.
